BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 24590673)

  • 1. Prognostic value of total tumor volume in advanced-stage laryngeal and hypopharyngeal carcinoma.
    Yang CJ; Kim DY; Lee JH; Roh JL; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2013 Dec; 108(8):509-15. PubMed ID: 24590673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implication of computed tomography findings in patients with locally advanced squamous cell carcinoma of the larynx and hypopharynx.
    Ryu IS; Lee JH; Roh JL; Choi SH; Nam SY; Kim SY; Cho KJ
    Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):2939-45. PubMed ID: 25149290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx.
    Roh JL; Pae KH; Choi SH; Kim JS; Lee S; Kim SB; Nam SY; Kim SY
    Eur J Surg Oncol; 2007 Aug; 33(6):790-5. PubMed ID: 17306956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
    Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
    Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of computed tomography-based tumor volume as a predictor of outcomes in hypopharyngeal cancer after treatment with definitive radiotherapy.
    Chen SW; Yang SN; Liang JA; Tsai MH; Shiau AC; Lin FJ
    Laryngoscope; 2006 Nov; 116(11):2012-7. PubMed ID: 17075415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas.
    Roh JL; Kim JS; Kang BC; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2014 Dec; 110(7):869-75. PubMed ID: 25088392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laryngeal or hypopharyngeal squamous cell carcinoma: can follow-up CT after definitive radiation therapy be used to detect local failure earlier than clinical examination alone?
    Hermans R; Pameijer FA; Mancuso AA; Parsons JT; Mendenhall WM
    Radiology; 2000 Mar; 214(3):683-7. PubMed ID: 10715030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of hypoxia-associated markers in advanced larynx and hypopharynx squamous cell carcinoma.
    Bernstein JM; Andrews TD; Slevin NJ; West CM; Homer JJ
    Laryngoscope; 2015 Jan; 125(1):E8-15. PubMed ID: 25230150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx.
    Daly ME; Le QT; Jain AK; Maxim PG; Hsu A; Loo BW; Kaplan MJ; Fischbein NJ; Colevas AD; Pinto H; Chang DT
    Head Neck; 2011 Jan; 33(1):103-11. PubMed ID: 20848427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node ratio as a prognostic marker in advanced laryngeal and hypopharyngeal carcinoma after primary total laryngopharyngectomy.
    Grasl S; Janik S; Parzefall T; Formanek M; Grasl MC; Heiduschka G; Erovic BM
    Clin Otolaryngol; 2020 Jan; 45(1):73-82. PubMed ID: 31660699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.
    Abd El-Hafez YG; Moustafa HM; Khalil HF; Liao CT; Yen TC
    Oral Oncol; 2013 Mar; 49(3):261-8. PubMed ID: 23036774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery-based versus radiation-based treatment strategy for a high metabolic volume laryngeal cancer.
    Yabuki K; Sano D; Shiono O; Arai Y; Chiba Y; Tanabe T; Nishimura G; Takahashi M; Taguchi T; Kaneta T; Hata M; Oridate N
    Laryngoscope; 2017 Apr; 127(4):862-867. PubMed ID: 27576793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systematic analysis of cervical lymph node metastasis of larynx and hypopharynx carcinomas--a clinical computerized tomography study with special reference to extension of the primary tumor].
    Pfreundner L; Pahnke J; Desing A; Schindel M
    Laryngorhinootologie; 1996 Oct; 75(10):602-10. PubMed ID: 9035664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of actual tumor growth rate on disease free survival and overall survival in laryngeal squamous cell carcinoma.
    van Bockel LW; Verduijn GM; Monninkhof EM; Pameijer FA; Terhaard CH
    Radiother Oncol; 2014 Jul; 112(1):119-24. PubMed ID: 24993330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid cartilage invasion in laryngeal and hypopharyngeal squamous cell carcinoma treated with total laryngectomy.
    Koopmann M; Weiss D; Steiger M; Elges S; Rudack C; Stenner M
    Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3789-3794. PubMed ID: 27256366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of metabolic tumor volume measured by 18F-FDG PET/CT in advanced-stage squamous cell carcinoma of the larynx and hypopharynx.
    Park GC; Kim JS; Roh JL; Choi SH; Nam SY; Kim SY
    Ann Oncol; 2013 Jan; 24(1):208-14. PubMed ID: 23002280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus.
    Kim JW; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2013 May; 49(5):449-53. PubMed ID: 23321549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.